Liver sinusoidal endothelial cells (LSECs) are organ resident APCs capable of antigen presentation and subsequent tolerization of T cells under physiological conditions. In this study, we investigated whether LSEC pretreatment with NOD-like receptor (NLR) agonists can switch the cells from a tolerogenic to an immunogenic state and promote the development of T cell immunity. LSECs constitutively express NOD1, NOD2 and RIPK2. 
Introduction
NOD-like receptors (NLRs), germline-encoded pattern recognition receptors (PRRs), play a crucial role in many inflammatory diseases in humans, highlighting their significant immunologic role (CoutermarshOtt et al., 2016) . Toll-like receptors (TLRs) are a group of transmembrane receptors that are able to recognize a large variety of microbialassociated molecular patterns (MAMPs) from different pathogenic microorganisms and induce the activation of the innate immune system. NLRs recognize specific pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) or sense changes in the intracellular environment following virus infection (Coutermarsh-Ott et al., 2016; Caruso et al., 2014; Philpott et al., 2014) . The NOD protein family comprises more than 20 members identified in humans and more than 30 in mice, including NOD1 and NOD2. NOD1 specifically recognizes γ-d-glutamyl-meso-diaminopimelic acid (iE-DAP) released from predominantly gram-negative bacterial organisms (Travassos et al., 2010; Moreira and Zamboni, 2012; Kim et al., 2008) . NOD2 recognizes uramyl dipeptide (MDP), a peptidoglycan (PGN) motif widely distributed among both gram-positive and gram-negative https://doi.org/10. 1016/j.molimm.2018.06.002 T bacteria, as well as DNA and RNA virus genomes (Sabbah et al., 2009; Kim et al., 2011) . Recent studies using a HEK293 transfection system, dendritic cells and hepatocytes demonstrated that NOD1 and NOD2 associate with receptor-interacting protein kinase 2 (RIPK2)/RICK via CARD-CARD interactions, which allow RIPK2 to associate with TRAF6/ TAK1, subsequently leading to the activation of NF-κB and MAPK and the upregulation of inflammatory mediators such as interleukin (IL)-6 and tumour necrosis factor alpha (TNF-α) (Tukhvatulin et al., 2011; Scott et al., 2010; Hasegawa et al., 2008a; Lupfer et al., 2014) . Moreover, following the recognition of viral ssRNA genomes in 293 cells and A549 cells, NOD2 utilized the adaptor protein MAVS (mitochondrial antiviral signalling) to activate IRF3, leading to the production of interferon-β (IFN) (Sabbah et al., 2009) . However, the immune responses elicited by Nod stimulation in non-parenchymal liver cells are poorly characterized.
The liver is a sentinel organ in a unique position to induce tolerance rather than immunity towards antigens that are presented locally to T cells (Knolle and Limmer, 2001; Knolle and Thimme, 2014; Kern et al., 2010a) . The immune response in the liver is regulated by the unique hepatic microenvironment rich in gut-derived food and bacterial degradation products and by liver resident cells with unique functions, such as liver sinusoidal endothelial cells (LSECs), hepatocytes, Kupffer cells (KCs) and DCs, which are involved in antigen-specific tolerance induction (Breous et al., 2009; Crispe, 2003) . Among these different cell populations, LSECs are particularly important because they are strategically located in the liver sinusoids to interact with passenger leukocytes, which constitute a unique organ-resident cell population that bears APC function, induces CD8 + T-cell tolerance, and takes up more hepatotropic viruses (such as HBV and hepatitis C virus) from the blood than other hepatic cells during viral infection (Limmer et al., 2000; Kern et al., 2010b) . Tolerance induction by LSECs can be broken by different regulatory mechanisms, such as exogenous IL-2 and promotion of CD28 signalling, which can overcome PD-L1-mediated inhibitory signals, interfere with LSEC-induced T cell tolerance, and induce IFN-γ production by Th1 cells (Schurich et al., 2010) . Palmitoyl-3-cysteine-serine-lysine-4 (P3C; TLR1/2 ligand) pretreatment of LSECs induces proliferation and IFN-γ production of allogeneic or Ag-specific CD4 + T or CD8 + T cells mediated by IL-12 production (Liu et al., 2013 ). Viral infection with murine cytomegalovirus caused functional maturation of antigen-presenting LSECs and was sufficient to promote antigen-specific differentiation into effector CD8 + T cells, independent of CD80/86, CD40/CD40 L, or IL-12 (Kern et al., 2010b; Bottcher et al., 2011) . However, it is still unclear whether the ligation of NLRs can cause the functional maturation of LSECs and revert their suppressive properties to induce T cell immunity. In this study, we sought to determine whether LSECs express functional NOD receptors and whether NOD expression is altered in response to specific NOD ligands. We found that LSECs could respond to NOD1 ligands to activate NF-κB and MAPK, resulting in LSEC maturation and T cell activation, which mediated anti-HBV function both in vitro and in vivo.
Materials and methods

Animals
Wild-type C57BL/6 mice were obtained from Beijing HFK Bioscience CO. LTD (Beijing, China). The mice were used at 6-8 weeks of age. The animals were treated according to the Guidelines of the National Institutes of Health for Animal Care and Use. Ten micrograms of pSM2 (kindly provided by Mengji Lu from University Hospital of Essen, Essen, Germany) and pAAV-HBV1.2 (kindly provided by Professor Pei-Jer Chen from National Taiwan University College of Medicine, Taipei, Taiwan) were injected into the tail veins of 6-to 8-week-old mice in a volume of saline equivalent to 10% of the body mass of the mouse. The total volume was delivered within 5 to 8 s. The success of hydrodynamic injection (HI) was controlled by testing the levels of HBsAg and HBeAg in the serum 10 days post-HI. Mice negative for HBeAg were excluded from the experiments.
Reagents
Agonists for TLR3 (Poly(I:C)), NOD1 (C12-iE-DAP) and NOD2 (MDP) were purchased from InvivoGen (San Diego, CA).
LSEC isolation and cell culture
Isolation of LSECs and splenocytes was performed as described previously (Wu et al., 2007) . The purity of the cell fractions was monitored by flow cytometry and was greater than 98% in all cases. All cell fractions contained less than 5% dead cells after the separation procedure.
Flow cytometry
Cell-surface and intracellular staining for flow cytometric analysis was performed using BD Biosciences (Heidelberg, Germany) or eBioscience (Frankfurt, Germany) reagents. Intracellular IFN-γ and IL-2 staining was performed as described (Zelinskyy et al., 2006) . Data were acquired using a FACSCalibur flow cytometer (BD Biosciences) and analysed using FlowJo software (TreeStar, Ashland, OR). Cell debris and dead cells were excluded from the analysis based on scatter signals and 7-aminoactinomycin D (7AAD) fluorescence or Fixable Viability Dye eFluor 780 fluorescence.
Cytokine assays
LSECs treated without or with Poly(I:C), DAP and MDP were cultured at 2 × 10 6 cells/well in a total volume of 200 μl. Cell-free supernatants were collected and subjected to assays to measure IFN-γ, IL-6, IL-10, IL-2, IL-4, IL-17 A and TNF-α production using cytometric bead array (CBA) kits (BD Biosciences) and to detect IFN-α, IFN-β and TGF-β using commercially available kits (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Analysis of T cell function
Allogeneic responder T cells were isolated from BALB/c mice. The Poly(I:C)-, DAP-or MDP-stimulated or unstimulated LSECs were treated with mitomycin C (50 μg/ml) at 37℃ for 30 min followed by washing with medium and resuspension in an appropriate volume of culture medium. 
Western blotting
Cells were lysed in 1 x SDS loading buffer. Aliquots of proteins from cell lysates were electrophoresed on 10% (w/v) polyacrylamidegels and transferred onto nitrocellulose membranes (Schlei-cher & Schuell, Kassel, Germany). The blot was probed with antibodies for phosphorylated forms of p65 or p38 MAPKs (Cell signalling technology) or β-actin (Sigma, St. Louis, MO, USA) and HRP-conjugated secondary antibodies were applied. Then the membranes were washed with PBS with 0.1% Tween 20, incubated in LumiLight working solution (GE Health-care, Piscataway, NJ, USA) and exposed to X-ray films.
RNA isolation and real-time reverse transcription (RT-PCR)
Total RNA was isolated from mouse LSECs using E.Z.N.A Total RNA Kit (Omega, Norcross, GA) following the manufacturer´s protocol. Onestep RT-PCR with real-time detection was carried out with the SYBR Green Real-time RT-PCR Master Mix (Toyobo, Osaka, Japan). The mRNA levels of CCL2, CCL3,CCL4, CCL5, CCL7, CCL8, CXCL2, CXCL9, CXCL10, CXCL11, IL-6, IL-10, IL-2, TGF-β, IFN-β, IFN-γ, ISG-15, and TNF-α (Table 1) was detected by commercial Quantitec Primer Assays (Qiagen, Hilden, Germany).
HBV replication and adoptive cell transfer
Chronic HBV infection was established as described previously (Huang et al., 2006) . Adoptive cell transfers were performed by HI of 0.5 ml PBBS containing 15 U/ml heparin and 5 × 10 6 purified T cells, as indicated at day 14 post-infection.
Detection of serological markers of HBV infection
Mouse sera were diluted 1:10 with Diluent Universal (Roche Diagnostics), and HBsAg and HBeAg were detected using an ECLIA system (Roche Diagnostics) according to the manufacturer's instructions. Serum HBV DNA was extracted using a QIAamp MinElute Virus Spin kit (Qiagen, Hilden, Germany) and was quantitatively detected by real-time PCR using the SYBR Green real-time PCR master mix (Toyobo, Osaka, Japan). Seven mice were included per group.
Statistical analysis
The data are presented as the mean ± standard deviation (SD). Experimental results are analysed for their significance by Student's ttest. When more than two groups were compared, a one-way ANOVA was used with a Tukey posttest. Significance was established at 95% confidence.
Results
LSECs express NOD1, NOD2, and RIPK2
We first examined whether primary isolated mouse LSECs expressed NOD1, NOD2, and RIPK2 at baseline. We isolated RNA from C57BL/6 mouse LSECs cultured overnight and performed quantitative PCR using validated specific primers for NOD1, NOD2, and RIPK2 (Kobayashi et al., 2002) . As shown in Fig. 1 , LSECs constitutively expressed low levels of NOD2 mRNA, moderate levels of RIPK2 mRNA and high levels of NOD1 mRNA.
We then determined whether the stimulation by DAP (a NOD1 ligand), MDP (a NOD2 ligand), or Poly(I:C) (a TLR3 ligand) would increase the expression of NOD1, NOD2, or RIPK2 in LSECs. RIPK2 expression was significantly upregulated in LSECs by Poly(I:C) and DAP treatment, and it was also upregulated to a lesser extent by MDP, but this difference was not significant (Fig. 1 ). RIPK2 expression induced by Poly(I:C) is controversial. Previous studies have suggested that RIPK2 is involved in TLR signalling primarily due to TLR agonists that contain NOD1-and NOD2-stimulating impurities (Park et al., 2007) . Indeed, recent studies demonstrated that RIPK2 is specifically required for NOD1 and NOD2 signalling but not for TLR pathways. NOD1 and NOD2 mRNA expression was slightly increased 6 h after stimulation with DAP, MDP and Poly(I:C), but this difference was not significant (Fig. 1) , and ISG15  QT00322749  IFN-β  QT00249662  IFN-γ  QT01038821  IL-6  QT00098875  IL-10  QT00106169  TGF-β  QT00145250  TNF-α  QT00104006  IL-2  QT00112315  CXCL2  QT00113253  CXCL9  QT00097062  CXCL10  QT00093436  CXCL11  QT00265041  CXCL12  QT00161112  CCL2  QT00167832  CCL3  QT00248199  CCL4  QT00154616  CCL5  QT01747165  CCL7  QT00171458  CCL8 QT00128548 β-actin QT01136772 Fig. 1 . Analysis of NOD1, NOD2, and RIPK2 expression in murine LSECs. LSECs were cultured for 24 h and an additional 6 h after stimulation with DAP (A), MDP (B) and Poly(I:C) (C). NOD1, NOD2 and RIPK2 expression were measured by real-time RT-PCR. The copy numbers of transcripts were normalized to β-actin (no. of copies/100,000 copies β-actin). The difference between the groups was analysed using an unpaired Student's t-test Statistically significant differences between the groups are indicated: *, P < 0.05.
the underlying mechanisms involved remain to be elucidated. These data indicate that the regulation of NOD1 and NOD2 signalling in LSECs may occur through the recruitment of RIPK2.
NOD1, but not NOD2, ligand directly activates NF-κB and MAPK in LSECs
Next, we determined whether LSECs are activated by specific ligands for NOD1 and NOD2. It was previously shown that the activation of the NOD1 and NOD2 pathways occurred through RIPK2 in dendritic cells, hepatocytes and primary fibroblasts, resulting in NF-κB and MAPK activation (Sabbah et al., 2009; Scott et al., 2010; Lupfer et al., 2014; Farzi et al., 2015) . Stimulation of mouse LSECs with DAP activated p38 MAPK to similar levels as stimulation with Poly(I:C) at 0.5 h and 1 h. The level of p-p65 NF-κB of DAP stimulated LSECs was comparable to that of Poly(I:C) stimulated LSECs at 1 h, but not for 0.5 h (Fig. 2) . However, MDP stimulation only resulted in a slight increase of NF-κB and MAPK activation in LSECs at 0.5 h (Fig. 2) , possibly due to low levels of NOD2 and RIPK2 expression (Fig. 1) . These data are also consistent with the results suggesting that DAP is able to enter cells more rapidly and efficiently than MDP to activate intracellular NOD receptors.
NOD1 stimulation mediated the activation and maturation of LSECs
It has been shown that NF-κB and MAP kinase activation resulting from NOD1 or NOD2 stimulation could upregulate cytokine and chemokine production (Scott et al., 2010) . We therefore determined whether cytokine and surface marker expression was induced in murine LSECs treated for up to 6 h with DAP, MDP or Poly(I:C).
As shown in Fig. 3(A) , LSECs constitutively expressed very low levels of IFN-γ, IL-2 and IL-10; moderate levels of ISG-15, IFN-β, and TNF-α; and high levels of TGF-β and produced low levels of TNF-α and IL-6. IFN-γ, TNF-α, and IL-2 expression was highly upregulated in LSECs by DAP stimulation (Fig. 3A) . Poly(I:C) obviously increased the levels of many cytokines, including ISG-15, IFN-β, IFN-γ, TNF-α and IL-2, in LSECs after 6 h (Fig. 3A) . Exposure of LSECs to MDP did not induce any increase in cytokines, which may be due to the lack of activation of the NF-κB and MAPK pathways or the decreased recruitment of RIPK2. TGF-β and IL-10 expression was decreased in response to DAP, MDP, and Poly(I:C). Then, we examined the IL-2, IFN-γ, IL-10, TNF-α, IL-6 protein expression using cytometric bead array kits and IFN-α, IFN-β and TGF-β using commercially Elisa kits (Fig. 3B) . The secretion of IFN-β, TNF-α and IL-6 was significantly upregulated by DAP and Poly(I:C), but not by MDP (decreased, but no significance), which was consistent with the mRNA levels (Hasegawa et al., 2008b) . The release of TGF-β in LSEC was down-regulated in response to DAP and MDP (Fig. 3B) . However, the secretion of IL-2, IFN-α, IFN-γ and IL-10 in the culture supernatants was induced at undetectable levels by DAP, MDP, and Poly(I:C), which indicated that the post-transcriptional regulation factors inhibited cytokine release.
DAP stimulation significantly upregulated the expression of CXCL2 (neutrophil trafficking), CXCL9 (Th1, CD8, NK trafficking), CCL2 (inflammatory monocyte trafficking), CCL7 (monocyte mobilization) and CCL8 (Th2-type CD4 T cells) (Fig. 3C) . Poly(I:C) significantly induced more cytokines to much higher levels, including CXCL2, CXCL9, CXCL10 (Th1 type CD4 T cell, CD8, NK trafficking), CCL2, CCL5 (macrophage and NK cell migration; T cell-DC interactions), CCL7 and CCL8 expression in LSECs, whereas CXCL12 expression was significantly suppressed in LSECs by DAP and Poly(I:C), which mediated bone marrow homing and enhance the immune response (Fig. 3C) . The impact of MDP stimulation on chemokine expression in LSECs was not obvious (Fig. 3C ). These data suggest that activation of LSECs by DAP and Poly(I:C) may provide opportunities for immune cell migration to the liver and induce the innate and adaptive response.
To further clarify the mechanisms of the functional maturation of LSECs, the expression levels of major histocompatibility complex (MHC) class II, the costimulatory molecules CD40, CD80, and CD86, the co-inhibitory molecule PD-L1, and the adhesion molecules CD54 and CD106 on LSECs were examined (Fig. 3D) . As observed in Fig. 3 , in contrast to the cytokine production results, neither MDP nor DAP stimulation could upregulate the expression of MHC-II, CD80, CD106, CD54, but CD40, CD86. Our previously published study showed that Poly(I:C) stimulation could not upregulate the expression of MHC-II, CD40, CD86 or CD80, which was consistent with other studies (Liu et al., 2013; Wu et al., 2010) . In contrast, MDP and DAP stimulation slightly upregulated the expression of the co-inhibitory molecule PD-L1 on LSECs (Fig. 3C) . Collectively, LSEC activation and maturation induced by DAP stimulation may partially be due to the upregulation of cytokine and chemokine expression.
Pretreatment of LSECs with DAP, but not MDP, upregulated the allogeneic T cell-mediated induction of IL-2 production
To investigate whether DAP-pretreated LSECs enhance the T-cell response, primary allogeneic T cells were isolated. The proliferation of allogeneic T cells and the production of cytokines (IL-2/IFN-γ) in an MLR were detected. LSECs pretreated with DAP or MDP behaved like untreated LSECs and could not enhance allogeneic CD4+ and CD8 + T cell proliferation, despite the upregulation of MHC-II, CD40, CD86 and CD54 (Fig. 4A-B) . Poly(I:C) stimulation also could not induce the activation of CD4 + and CD8 + T cells, which was consistent with our published data (Wu et al., 2010) . Pretreatment of LSECs with DAP could significantly enhance IL-2 production by allogeneic CD4 + and CD8 + T . Differences among multiple groups were analysed by one-way ANOVA. Statistically significant differences among multiple groups are indicated: *, P < 0.05; **, P < 0.01; ***, P < 0.001. cells on day 5, but not on day 3 (Fig. 4) . The IL-2 levels were comparable to those observed in MLRs with Poly(I:C)-treated LSECs, indicating that the influence of DAP-treated LSECs on allogeneic CD4 and CD8 T cells was time-dependent (Fig. 4) . MDP-stimulated LSECs failed to stimulate IL-2-production by allogeneic CD8 + or CD4 + T cells on days 3 or 5. We also assessed IFN-γ production in MLRs. Unfortunately, we found that DAP-, MDP-, and Poly(I:C)-stimulated LSEC could not induce the release of IFN-γ by allogeneic CD4 + or CD8 + T cells on days 3 or 5. These data suggested that IL-2, but not IFN-γ, plays an important role in the process of the innate and adaptive immune response mediated by DAP-treated LSECs.
DAP-stimulated LSECs enhanced the CD8 + T cell response in vitro and in vivo
Next, we estimated whether DAP-stimulated LSECs may elicit HBVstimulated T cell immunity. To verify this hypothesis, we isolated CD8 + T cells from the spleen of an acute HBV replication mouse model. CD8 + T cells were cocultured with untreated versus treated peptide-loaded LSECs treated with DAP, MDP, or Poly(I:C). We found that DAP, MDP or Poly(I:C) could slightly increase the proliferation of HBcAg-stimulated T cells (Fig. 5A) . MDP treatment failed to induce IL-2 or IFN-γ production by HBcAg-or HBsAg-stimulated CD8 T cells (Fig. 5B) . In contrast, DAP-stimulated LSECs significantly increased IL-2 production by HBcAg-stimulated CD8 T cells. Poly(I:C)-stimulated LSECs induced marked IFN-γ production by HBcAg-stimulated T cells and IL-2-production by HBcAg-and HBsAg-stimulated T cells (Fig. 5B) . These data indicated that pretreatment of LSECs with DAP, but not with MDP, allows cytokine production (IL-2, IFN-γ) by T cells in vitro.
We further examined whether DAP or MDP-stimulated LSECs indeed prime CD8 + T cells with antiviral function in vivo. To answer this question, we further explored the hydrodynamic injection mouse model to test the T cell function. CD8 + T cells were primed with HBV peptideloaded LSECs that were treated with DAP, MDP, or Poly(I:C) or untreated in vitro and then transferred into mice with chronic HBV replication. T cells preincubated with untreated or MDP-pretreated LSECs failed to exhibit any anti-HBV activity in vivo, without any reduction of serum HBsAg, HBeAg or HBVDNA. The level of HBsAg and HBeAg in the transferred mouse T cells pre-primed by DAP-and Poly(I:C)-treated LSECs was significantly decreased compared with that of unstimulated LSECs (Fig. 5C-D) . Consistent with this, there was a reduction in the viral loads in mice that received T cells pre-primed with DAP-pretreated LSECs compared with that of unstimulated LSECs or MDP-treated LSECs, but this difference was not significant (Fig. 5E ). The serum HBVDNA in mice receiving transferred T cells pre-primed with Poly (I:C)-pretreated LSECs was significantly decreased. These results clearly demonstrated that DAP stimulation of LSECs can shift T cell tolerance towards antiviral T cell immunity.
Discussion
In this study, we found that LSECs express high levels of NOD1 and Differences among multiple groups were analysed by one-way ANOVA. *P < 0.05; **, P < 0.01; ***, P < 0.001.
low levels of NOD2. DAP stimulation of LSECs leads to the activation of NF-κB and MAP kinases; the upregulated expression of chemokines (CXCL2/9, CCL2/7/8) and cytokines (IFN-γ, TNF-α and IL-2); the increased production of IL-6, TNF-α, and the co-inhibitory molecule PD-L1; increased IFN-γ and IL-2-production by allogeneic T cells; and increased IFN-γ and IL-2-production by HBV-specific T cells. LSECs stimulated with MDP only can induce the upregulation of the co-inhibitory molecule PD-L1. T cells pre-primed by DAP-treated LSECs can inhibit HBV expression and replication in vivo. Taken together, these data demonstrate that NLR stimulation of LSECs leads to distinct LSEC maturation and enhanced T cell immunity. Many liver cell types, including LSECs and hepatocytes, tend to express the NOD1 receptor and may induce synergistic immunity against pathogens. Scott et al reported that stimulation of hepatocytes with NOD1 ligand (C12-iEDAP) induced the expression of the chemokine KC (CXCL1), which mediated neutrophil trafficking, and RANTES (CCL5), which was produced later in the immune response and was responsible for recruiting T cells and innate-type lymphocytes, such as macrophages and NK cell (Masumoto et al., 2006) . The data from this study suggest that DAP is a more potent inducer of chemokines in LSECs than in hepatocytes. We found that stimulation of LSECs with DAP led to the production of chemokines, including CXCL2, which recruited neutrophils; CCL2/7, which recruited inflammatory monocytes; CCL8, which recruited Th2-type CD4 + T cells; and CXCL9, which recruited Th1, CD8, and NK cells. This indicates that LSECs secrete several chemokines, recruit immune cells to the liver and play an important role in different phases of infection (Werts et al., 2007) . It is well known that LSECs located in the liver sinusoids are the first detectors of pathogens circulating in the liver (Kern et al., 2010a; Bottcher et al., 2011) . If LSEC activation was not sufficient to induce a protective immune response against the infection, hepatocytes recognized MDP and increased their expression of CXCL1 and CCL5, which further promoted the recruitment of neutrophils, macrophages and NK cells to the liver, indicating that LSECs and hepatocytes may cooperate to jointly clear the invading pathogens.
The data from this study suggest that stimulation of LSECs with DAP strongly activated NF-κB and MAPK in LSECs, leading to the production of antiviral and pro-inflammatory cytokines, and upregulated the T cells isolated from pSM2-immunized mice were cocultured with 2 μg/ml HBcAg peptide-pulsed LSECs that were treated with 100 μg/ml Poly(I:C), 10 μg/ml DAP, or 10 μg/ml MDP or left untreated (unstimulated LSECs). After 72 h, the T cells were harvested and washed with PBS, and 5 × 10 6 purified T cells were adoptively transferred into recipient mice which were at day 14 post-HBV infection. The level of serum HBsAg (C), HBeAg (D) and viral loads (E) were detected at the indicated time points. The cut-off value of the HBsAg and HBeAg assays was 1.0 COI (cut-off index). The cut-off value of the HBV DNA real-time PCR was 5 × 10 2 copies/ml. The data shown are the mean ± SD of one of two representative experiments. Differences among multiple groups were analysed by one-way ANOVA. * indicates a significant difference between DAP-LSEC and MDP-LSEC (D) or DAP-LSEC and unsti-LSEC groups at p < 0.05. # and ## indicates a significant difference Poly(I:C)-LSEC and MDP-LSEC (D) or Poly(I:C)-LSEC and unsti-LSEC groups at p < 0.05 and P < 0.01, respectively. expression of surface markers on LSECs, which subsequently induced T cell activation in vitro and in vivo. Other studies have also suggested that LSEC functional maturation could lead to the generation of effector T cells (Schurich et al., 2010; Bottcher et al., 2014) . Coculture of naive ovalbumin (OVA)-specific TCR-transgenic CD8 + T cells (OT-I) with LSECs cross-presenting OVA resulted in rapid T cell activation, which required increased interleukin-6 (IL-6). The addition of exogenous IL-2 led to Ag-specific cytotoxicity and the generation of IFN-γ-producing effector T cells from naive CD8 T cells primed by cross-presenting LSECs in a dose-dependent fashion, demonstrating that IL-2 is a costimulatory factor promoting CTL differentiation locally via cross-presenting LSECs. Moreover, IL-10 downregulates T cell activation by LSECs through decreased antigen uptake via the mannose receptor and lowered surface expression of the accessory molecules CD80, CD86 and MHC class II (Knolle et al., 1998) . This is in accordance with our data indicating that DAP application increased the expression of IL-2 and IL-6 and decreased IL-10 expression in vitro, suggesting that IL-2, IL-6 and IL-10 induced LSEC maturation and subsequent T cell activation. Although PD-L1 expression on LSECs was increased, we observed LSEC maturation, indicating that IL-10 is not sufficient to drive LSEC tolerance in this situation with increased IL-2, IL-6 and decreased IL-10. Schurich et al also reported that exogenous IL-2 during the initial contact of naïve CD8 T cells with tolerogenic cross-presenting LSECs overrode co-inhibitory PD-L1-mediated signals by LSECs and induced the generation of IFN-γ-producing effector T cells in a dose-dependent fashion (Schurich et al., 2010) . Thus, these data indicate that DAP stimulation can induce LSEC activation, leading to breaking LSEC-induced T cell tolerance.
In this study, we found that MDP stimulation has no impact on LSECs or on HBV-specific T cells primed by MDP-treated LSECs. From our study, as well as studies by others, it seems likely that MDP is not easily able to enter cells to stimulate NOD2 (Lee et al., 2009 ). Scott et al reported that MDP stimulation did not increase the expression of NOD2 or RIP2 and resulted in only a minimal increase of NF-κB activation in hepatocytes (Scott et al., 2010) . Abbott et al also reported that MDP stimulation was unable to induce NOD2 expression in wild-type MEFs; this observation may have been due to a defect in MDP transport to the cytoplasm (Abbott et al., 2007) . However, increasing evidence indicates the opposite result, that NOD2 can be activated by MDP. MDP stimulation induced increased IFN-γ and IL-8 production and CD83 expression on DCs in vitro (Tada et al., 2005) . MDP treatment induced the activation of NF-κB in 293 cells (Sabbah et al., 2009 ). Thus, we speculate that NOD2-induced immune responses are cell type-specific. DAP stimulation showed little impact on LSECs and hepatocytes. NOD2 may be a target for regulating concanavalin A-induced liver injury (BodyMalapel et al., 2008) . These findings suggest that NOD2 may play an important role in many pathogen infection processes involving the liver.
The data presented in this study provide important insights into the mechanism of activation of LSECs during infection and inflammation. Our findings indicate that LSECs express not only TLRs, as previously shown, but also NOD1 and that they respond to specific ligands for these receptors. Thus, it is likely that LSEC maturation mediated by NOD1 may play an important role in the innate and adaptive immune systems in the liver against infection.
